ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "osteoporosis"

  • Abstract Number: 0107 • ACR Convergence 2020

    Effects of Abaloparatide on Modeling and Remodeling Based Bone Formation

    David W Dempster1, Hua Zhou1, Sudhaker D Rao2, Chris Recknor3, Paul D Miller4, Benjamin Z Leder5, Miriam Annett6, Michael S Ominsky6 and Bruce H Mitlak6, 1Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, West Haverstraw, NY, 2Bone & Mineral Research Laboratory, Henry Ford Health System, Detroit, MI, Detroit, MI, 3United Osteoporosis Centers, Gainesville, GA, Gainesville, GA, 4Colorado Center for Bone Research, Lakewood, CO, Lakewood, CO, 5Mass General Hospital, Harvard Medical School, Boston, MA, Boston, MA, 6Radius Health, Inc., Waltham, MA, Waltham, MA

    Background/Purpose: To evaluate abaloparatide-induced changes in the bone formation indices of mineralizing surface (MS), bone formation rate (BFR) and mineral apposition rate (MAR); and to…
  • Abstract Number: 0125 • ACR Convergence 2020

    A Resident-Led Interdisciplinary Quality Improvement Initiative to Increase Osteoporosis Screening in an Urban Clinic

    Catherine Teskin1 and Hiba Sayed2, 1Christiana Care, Wilmington, 2Christiana Care, wilmington, DE

    Background/Purpose: Osteoporosis is a major cause of morbidity and mortality in the United States. The USPSTF recommends screening all women age 65 and older or…
  • Abstract Number: 1337 • ACR Convergence 2020

    Relationship of the Pro12Ala Polymorphism of the PPARg Gene with Inflammatory Activity, Osteoporosis and Obesity in Patients with Psoriatic Arthritis

    Olga Compán1, Maria Elisa Acosta2, Sonia Pastor2, Guadalupe Manzano Canabal2, Luis Gomez-Lechon Quiros3, Cristina Hidalgo Calleja4, Noelia Cubino2, Ricardo Usategui5, Rogelio Gonzalez Sarmiento5, Olga Martinez Gonzalez6, Ana Isabel Turrión2, Javier Del Pino-Montes2 and Carlos Montilla Morales2, 1Hospital Universitario de Salamanca, ´Salamanca, Spain, 2Hospital Universitario de Salamanca, Salamanca, Spain, 3Complejo Asistencial Universitario de Salamanca, Salamanca, Spain, 4Hospital Universitario Salamanca, Salamanca, Spain, 5Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain, 6Hospital Universitario de Salamanca, Zamora, Spain

    Background/Purpose: In the pathogenesis of psoriatic arthritis (PsA), increased inflammatory cytokines lead to increased RANGO-L activity and stimulation of osteoclasts, leading to osteoporosis. This comorbidity,…
  • Abstract Number: 0108 • ACR Convergence 2020

    The Relationship Between Body Fat Percentage and Bone Mineral Density in Rheumatoid Arthritis Patients

    Anastasia- Vasiliki Madenidou1 and Marwan Bukhari2, 1Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Barrow-in-Furness, United Kingdom, 2Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom

    Background/Purpose: Currently, Dual-Energy X-ray Absorptiometry (DEXA) scans are used to determine fracture risk by calculating Bone Mineral Density (BMD). It is well established that body…
  • Abstract Number: 0127 • ACR Convergence 2020

    Biochemical Algorithm to Identify Individuals with ALPL Variants Between Subjects with Persistent Hypophosphatasaemia

    Carolina Tornero1, Victoria Navarro-Compán2, Jair Antonio Tenorio3, Sara Garcia-Carazo4, Antonio Buño5, Irene Monjo1, Chamaida Plasencia6, José Manuel Iturzaeta5, Pablo Lapunzina7, Karen Heath7, Alejandro Balsa6 and Pilar Aguado8, 1Rheumatology, La Paz University Hospital- IdiPAZ, Madrid, Spain, 2Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain, 3Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital-IdiPAZ, Madrid, Madrid, Spain, 4Rheumatology, La Paz University Hospital-IdiPAZ, Madrid, Melilla, Spain, 5Department of Clinical Biochemistry, La Paz University Hospital, Madrid, Madrid, Spain, 6Rheumatology, La Paz University Hospital-IdiPAZ, madrid, Spain, 7Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, IdiPAZ, Madrid, Madrid, Spain, 8Rheumatology, La Paz University Hospital-IdiPAZ, Madrid, Madrid, Spain

    Background/Purpose: Studies show a long diagnostic delay in Hypophosphatasia (HPP) and the accessibility for the genetic testing is not always possible. Our previous cross-sectional study…
  • Abstract Number: 1442 • ACR Convergence 2020

    Denosumab versus Oral Bisphosphonate for Osteoporosis in Long-term Glucocorticoid Users: A 12-month Randomized Controlled Trial

    Chi Chiu Mok1, Ling Yin Ho1 and Kwok Man Ma1, 1Tuen Mun Hospital, Hong Kong, China (People's Republic)

    Background/Purpose: To compare the efficacy of denosumab (DEN) and oral alendronate (ALN) on spinal bone mineral density (BMD) in long-term glucocorticoid users.Methods: Patients receiving long-term…
  • Abstract Number: 0109 • ACR Convergence 2020

    Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention?

    Eileen Rife1, Emejuaiwe Nkechinyere2 and Jose Leon de la Rocha3, 1Louisiana State University, Metairie, LA, 2Department of Veterans Affairs, New Orleans, LA, 3Louisiana State University, Auburn, AL

    Background/Purpose: Descriptive study designed to assess compliance to evidence-based practice guidelines for the prevention of Glucocorticoid-Induced Osteoporosis (GIOP).Methods: We queried the electronic database of the…
  • Abstract Number: 0129 • ACR Convergence 2020

    Glucocorticoid-Induced Osteoporosis in Patients with Chronic Inflammatory Rheumatic Diseases: A Multivariate Linear Regression Analysis Identifying Factors Affecting Bone Mineral Density

    Edgar Wiebe1, Desiree Freier1, Dörte Huscher2, Sandra Hermann1, Robert Biesen3 and Frank Buttgereit4, 1Charité University Medicine Berlin, Dep. of Rheumatology and Clinical Immunology, Berlin, Germany, 2Charité University Medicine Berlin, Dep. of Biometry and Clinical Epidemiology, Berlin, Germany, 3Charité University Medicine, Dep. of Rheumatology and Clinical Immunology, Berlin, 4Charité University Medicine, Berlin, Germany

    Background/Purpose: Rheumatic diseases are associated with increased systemic bone loss and fracture risk related to chronic inflammation, disease-specific, general and demographic risk factors as well…
  • Abstract Number: 1558 • ACR Convergence 2020

    Cinematic Rendering Enables Depiction of Bone Anabolic Effects in Patients Treated with Baricitinib

    Sara Bayat1, David Simon2, Louis Schuster2, Georg Schett3 and Arnd Kleyer2, 1Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 3Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany

    Background/Purpose: Preclinical studies show that tsDMARDs such as baricitinib may be a therapeutic agent for bone anabolic effects by increasing osteoblast function in inflammatory conditions.[1]…
  • Abstract Number: 0111 • ACR Convergence 2020

    Assessment and Treatment of Glucocorticoid-Induced Osteoporosis in a Rheumatology Clinic

    Amanda Stefl1, Shikha Singla2, Jessica Michaud1, Kama Thomas2, Lisa Rein2 and Mary Ellen Csuka2, 1Froedtert Hospital, Milwaukee, WI, 2Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: Glucocorticoids (GC) are used as a long-term treatment option for an estimated 1% of the US population. The American College of Rheumatology has maintained…
  • Abstract Number: 0130 • ACR Convergence 2020

    The Prevalence of Osteoporosis in Individuals with Osteoarthritis: A Systematic Review

    Timothy Varghese1, Ali Ahmadi Pirshahid2, Dongkeun Kim2 and Yueyang Li2, 1Schulich School of Medicine & Dentistry, Richmond Hill, ON, Canada, 2Schulich School of Medicine & Dentistry, London, ON, Canada

    Background/Purpose: There is controversy regarding the relationship between osteoarthritis (OA) and osteoporosis (OP). While OA may be associated with increased bone mineral density (BMD) due…
  • Abstract Number: 1588 • ACR Convergence 2020

    A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids

    Katherine Kaufman1, Philip Chu1, Mithu Maheswaranathan1, Andrew Johannemann1, D Ryan Anderson1, Isaac Smith1, Akrithi Udupa1, Mary Buckley1, Laura Cannon1, Rachel Randell1 and David Leverenz1, 1Duke University, DURHAM, NC

    Background/Purpose: The 2017 ACR guideline for glucocorticoid-induced osteoporosis (GIOP) recommends DXA testing in patients aged ≥40 years on chronic glucocorticoids. We performed a quality improvement…
  • Abstract Number: 0112 • ACR Convergence 2020

    Description of Risk Factors at Baseline and Need of Bone Agent According to Hadji Recommendations in Patients Taking Aromatase Inhibitors as Breast Cancer Therapy

    David Montero-Seisdedos1, Oihane Ibarguengoitia-Barrena2, Lucía Vega-Álvarez2, Carmen Lucía García Gomez2, Itziar Calvo-Zorrilla3, Juan M. Blanco-Madrigal2, Maria Esther Ruiz-Lucea2, María Luz García-Vivar2, Eva Galindez-Agirregoikoa2, Ana R. Inchaurbe-Pellejero2, Olaia Fernandez-Berrizbeitia2, Clara E. Perez-Velasquez2, Eduardo Cuende-Quintana4, Amaia Bilbao-González3 and Iñaki Torre-Salaberri3, 1Basurto University Hospital, Bilbao, Pais Vasco, Spain, 2Basurto University Hospital, Bilbao, Spain, 3University Hospital of Basurto, Bilbao, Pais Vasco, Spain, 4Basurto University Hospital, Madrid, Spain

    Background/Purpose: A well-known adverse effect of aromatase inhibitors (AI) in the bone is the loss of mineral density with the consequent increased risk of fracture…
  • Abstract Number: 0131 • ACR Convergence 2020

    Analysis of the Total Body Composition in a Cohort of Patients with Elderly Onset Arthritis

    Anahy María Brandy García1, Melania Martinez-Morillo2, Agueda Prior3, Rosa Serrano1, Lourdes Mateo4, Monica Guma5 and Laia Gifre2, 1Hospital Germans Trias i Pujol, Badalona, Spain, 2Hospital Germans Trias i Pujol, Barcelona, Spain, 3Department of Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, 4Department of Rheumatology, Germans Trias i Pujol. University Hospital, Badalona, Badalona, 5University of California San Diego, La Jolla, CA

    Background/Purpose: Inflammatory arthritis in the elderly leads to greater comorbidity than that of the young patients, however, there are few data on body composition in…
  • Abstract Number: 1590 • ACR Convergence 2020

    Bone Health in ANCA – Associated Vasculitis Patients

    Deepa Ragesh Panikkath1, Sandy Lee2 and Christina Downey2, 1Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, 2Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Glucocorticoids (GC) are an important mode of therapy in ANCA associated vasculitis (AAV), and osteoporosis (OP) and fractures are potential adverse effects seen. The…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.